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Objectives To find the antimicrobial susceptibility profile of 42 soil isolates of Nocardia asteroides against 14
antimicrobial agents representing b-lactams, aminoglycosides, ciprofloxacin, minocycline, erythromycin and
third generation cephalosporins.
Methods The antimicrobial susceptibility was determined by the disk diffusion method using Mueller–Hinton
agar medium. A homogeneous suspension giving an inoculum of 106–108 CFU/mL was used to streak the
plates. The zone of inhibition was read after 36–48 h of incubation at 37 °C.
Results All the soil isolates of N. asteroides were susceptible to amikacin, imipenem and tobramycin.
Susceptibility to cephalosporins was quite variable; 86% of the isolates were susceptible to cefotaxime, 57% to
ceftriaxone and 40% to cefamandole. Fifty-seven per cent of the isolates showed intermediate susceptibility to
cefamandole, 33% to ceftriaxone and 5% to cefotaxime. Ninety-three per cent of the isolates were resistant to
sulfamethoxazole alone or in combination with trimethoprim.
Conclusions The study reports a wide variation in the antimicrobial susceptibility profile of soil isolates of N.
asteroides originating from a single geographical area. Of interest is the finding that over 90% of N. asteroides
isolates were resistant to sulfamethoxazole without any previous exposure to this drug. This may have serious
therapeutic implications as sulphonamides or the combination of trimethoprim–sulfamethoxazole is the therapy
of choice for nocardiosis. Demonstration of resistance to b-lactam antibiotics may be attributed to the presence
of b-lactamases which was detectable in 90% of the soil strains of N. asteroides. The study underscores the
importance of antimicrobial susceptibility testing for clinical isolates of Nocardia since individual strains show
considerable differences in their susceptibility patterns necessitating therapeutic adjustments.
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INTRODUCTION
Among the actinomycetes, members of the genus Nocardia are,
with the exception of mycobacteria, the most commonly impli-
cated pathogens in human disease, mostly as opportunists [1].
The majority of infections are pulmonary in origin and the
organisms can disseminate through the hematogenous route to
any other organ/site [2,3]. With the introduction of sul-
phonamides as the drug of choice for nocardiosis, the fatality
rate has been reduced substantially [4]. However, instances
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of in vitro resistance and poor patient response to treatment,
including relapses, have been reported in recent years [3–5].
This has not only necessitated the use of alternative therapeutic
regimens but also underscored the importance of in vitro sus-
ceptibility testing of nocardia species to improve the therapeutic
outcome [3–7]. Moreover, the antimicrobial susceptibility pat-
tern has also been used as a basis for presumptive identification
of some of the nocardia species [8–10]. In this paper, we present
data on the antimicrobial susceptibility of 42 soil isolates of
Nocardia asteroides originating from a single geographical area.
MATERIALS AND METHODS
Bacterial strains and inoculum preparation
Strains of N. asteroides included in the study were isolated from
soil samples collected from different localities in Kuwait [11].
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Their identity was confirmed by standard biochemical tests
including their susceptibility to tobramycin and cefamandole to
exclude Nocardia farcinica [10,12]. Each test isolate was checked
for its purity and several colonies were emulsified into 50 mL
of Mueller–Hinton broth (Sanofi Diagnostics Pasteur, Mannes-
la-Conquette, France). The inoculated flasks were incubated at
37 °C for 24–48 h on a rotary shaker. Sterile glass beads (5 mm
in diameter) were added to each flask to minimize the formation
of clumps of nocardial growth during cultivation. Most of the
test strains yielded a uniform suspension of growth. The growth
so obtained was diluted 1 : 10 so as to give an approximate
concentration of 106–108 CFU/mL in accordance with the
recommendations of the National Committee of Clinical Lab-
oratory Standards (NCCLS) [13]. Reference strains of Esch-
erichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853,
Staphylococcus aureus ATCC 25923 and N. asteroides ATCC
19247 were used as controls to monitor the antimicrobial disk
susceptibility test [13].
Antimicrobial susceptibility testing
The soil isolates of N. asteroides were tested for their sus-
ceptibility to 14 antimicrobial agents by the disk diffusion
method [13]. The inoculum as prepared above, was spread with
a cotton swab on the surface of a square Petri dish (measuring
120 mm on each side) containing 50 mL of Mueller–Hinton
agar (MHA). Filter paper disks containing the NCCLS re-
commended concentrations of the antibiotics were used. Only
four antimicrobials were tested on each plate. The plates were
incubated at 37 °C after which the diameter of the clear zone
of inhibition including the size of the 6 mm disk was measured
in millimetres and recorded at 24 and 36–48 h. Occasionally,
readings were taken after 72 h for some strains in order to
confirm the results previously obtained.
Detection of b-lactamase activity
The b-lactamase activity of the isolates was determined by
Intralactam (ETo1) strips (Mast Diagnostics, Merseyside,
United Kingdom) following the directions of the manufacturer.
These strips had been impregnated with benzyl penicillin and
bromocresol purple in appropriate concentrations [14] and thus
were different from the nitrocefin (chromogenic cephalosporin)
method. Briefly, the strips were moistened with sterile distilled
water and growth from several well-isolated colonies from
MHA plates was smeared over them. The readings for color
change from purple to yellow were taken up to 1 h and recorded
as positive (+) and negative ().
Interpretation of susceptibility results
The response of each N. asteroides isolate to the antimicrobial
agent was graded as susceptible, intermediate susceptible and
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resistant on the basis of the criteria recommended by the Anti-
biogram Committee of the French Society for Microbiology
[15].
RESULTS
Antimicrobial susceptibility of soil isolates
The activity of the 14 antimicrobial agents against 42 isolates
of N. asteroides is presented in Table 1. All the soil isolates of N.
asteroides were susceptible to amikacin, imipenem and tobra-
mycin. With the exception of imipenem, susceptibility to other
b-lactams was quite variable; 86% of the isolates were sus-
ceptible to cefotaxime, 57% to ceftriaxone, 41% to cefa-
mandole, 21% to ampicillin and 5% to carbenicillin. Fifty-
seven per cent of isolates showed intermediate susceptibility to
cefamandole, 33% to ceftriaxone and 5% to cefotaxime.
Ninety-three per cent of the isolates were resistant to sul-
famethoxazole alone or in combination with trimethoprim
(TMP-SMX). The other antimicrobials which showed low
activity against N. asteroides strains included erythromycin (93%
resistant), ciprofloxacin (86%) and minocycline (55%).
b-lactamase activity
All the isolates demonstrated b-lactamase activity by Intralactam
strips. Twenty-eight strains showed positive reaction (+) within
5 min and 10 isolates showed a positive reaction gradually over
a period of 1 h. The four isolates that were initially negative for
b-lactamase activity became positive when they were sub-
cultured on MHA plates with amoxicillin-clavulanic disks and
colonies taken from near the zone of inhibition were retested
for b-lactamase activity.
DISCUSSION
The present study has two noteworthy features. Firstly, it
reports the antimicrobial susceptibility profile of 42 soil isolates
of N. asteroides from Kuwait, which is by far the largest number
of strains investigated from a saprobic source. Secondly, it
reports an unusually high prevalence of resistance to sul-
famethoxazole which is the drug of choice for the treatment of
nocardiosis [6,7]. The presence of in vitro resistance to sul-
famethoxazole in over 90% of naturally occurring isolates of
N. asteroides may have serious therapeutic implications as the
infection is acquired exogenously from soil [7]. Furthermore,
these isolates were not previously exposed to sulfamethoxazole
or to any other folate pathway antagonists thus excluding the
possibility of development of acquired resistance. However, to
what extent in vitro susceptibility data can be depended upon
in predicting therapeutic benefit is a controversial issue. Perhaps
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Table 1 Summary of
antimicrobial susceptibility
results of soil isolates of
N. asteroides
No. of isolates (%) in
susceptibility range
Antimicrobial Disk
agents potency Susceptible Intermediate Resistant
Ampicillin 10 mg 9 (21.4)** 14 (33.3) 19 (45.2)
Carbenicillin 10 mg 2 (4.8) 1 (2.4) 39 (92.9)
Ciprofloxacin 15 mg 5 (11.9) 1 (2.4) 36 (85.7)
Ceftriaxone 30 mg 24 (57.1) 14 (33.3) 4 (9.5)
Cefotaxime 30 mg 36 (85.7) 2 (4.8) 4 (9.5)
Imipenem 10 mg 42 (100) 0 0
Gentamicin 10 mg 13 (31) 21 (50) 8 (19.1)
Amikacin 30 mg 42 (100) 0 0
Minocycline 30 mg 13 (31) 6 (14.2) 23 (54.8)
Sulfamethoxazole 25 mg 3 (7.1) 0 39 (92.9)
TMP-SMX 1.25 + 23.75 mg 3 (7.1) 0 39 (92.9)
Erythromycin 15 mg 0 3 (7.1) 39 (92.9)
Tobramycin 10 mg 42 (100) 0 0
Cefamandole 30 mg 17 (40.5) 24 (57.1) 1 (2.4)
the state of the immune status of the host is crucial in deter-
mining the final outcome of the therapy.
A comparison of published reports on antimicrobial sus-
ceptibility profiles of N. asteroides revealed considerable dif-
ferences. These differences were particularly more marked with
respect to sulfamethoxazole and b-lactam antibiotics (Table 2)
[16–19]. Here it may be mentioned that most of the published
data on antimicrobial susceptibility of Nocardia are based on
Table 2 Comparative data on antimicrobial susceptibility profile of the soil and clinical isolates of Nocardia asteroides
% resistance
Present study Other studies on clinical isolates*
Antifungal Soil isolates Clinical isolates [16]a [17]b [18]b [19]a Resistance
agents n = 42 n = 3 n = 78 n = 98 n = 49 n = 40 range (%)
Ampicillin 45 66 60 82 73 60 45–82
Carbenicillin 93 100 72 NA NA 70 70–100
Ciprofloxacin 86 100 71 69 62 NA 62–100
Cefriaxone 10 0 18 16 2 0 0–18
Cefotaxime 10 0 18 21 2 0 0–21
Imipenem 0 33 12 11 23 8 0–33
Gentamicin 19 0 33 NA NA 30 0–33
Amikacin 0 0 5 NA 0 0 0–5
Minocyclin 55 66 0 6 6 23 0–66
Sulphamethoxazole 93 100 0 9 0 93 0–100
TMP-SMX 93 33 NA 9 0 93 0–93
Erythromycin 93 66 78 65 40 78 40–93
Tobramycin 0 0 NA NA 33 NA 0–33
Cefamandole 2 0 NA NA 37 60 0–60
a, Based on disk diffusion method; b, Based on minimum inhibitory concentration; NA, not available.
* References: [16] isolates submitted for susceptibility testing to Department of Microbiology, University of Texas Health Science Center; [17,
18] isolates referred to Actinomycete Laboratory, Division of Mycotic diseases, Centers for Disease Control, Atlanta; [19] isolates referred to
the National Reference Center for Mycoses and Antifungal agents, Institut Pasteur, Paris.
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clinical isolates received in reference laboratories from diverse
geographical regions. Some of these referral isolates may have
originated from patients who were unresponsive to or intolerant
of therapy. Moreover, the possibility that some of the strains of
N. asteroides included in early studies might have belonged to
N. farcinica or N. nova, cannot be excluded.
It is difficult to compare our in vitro susceptibility results with
data reported by other investigators because of different in
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methodology, such as lack of interlaboratory standardization of
inocula, or differences in interpretation criteria for resistance.
Moreover a strain may br inherently distinctive due to dif-
ferences in the source of origin (clinical, soil) or in the geo-
graphical origin.
The marked differences in the activity of sulfamethoxazole
and TMP-SMX which are may be attributed to three factors,
Firstly thymidine concentration of the medium. We used Muel-
ler-Hinton medium which is considered ideal for this purpose.
Secondly the inoculum size; we used an inoculum size of 106–
108 CFU/mL as per the NCCLS recommendations. Thirdly,
differences in the interpretative criteria of zone inhibition. We
have considered a strain susceptible to sulfamethoxazole when
clear zone of inhibition is observed around the disk. This is in
contrast to criterion used by other investigators who have used
80% inhibition criteria for the interpretation of TMP-SMX
susceptibility results. Most of the published data on anti-
microbial testing are based on clinical isolates received in ref-
erence laboratories. Since some of these isolates may have
originated from patients unresponsive to or intolerant of ther-
apy, there is a possibility of selection bias while comparing
susceptibility results.
In an early paper on the determination of sulphonamide
susceptibility for bacterial pathogens, Bauer and Sherris [20]
recommended that the point at which growth stops entirely or
is markedly decreased (80%) can be taken as the edge of the
inhibition zone. The growth within the zone is ignored. How-
ever, Nocardia was not included in this study. In subsequent
papers, Wallace et al. [6,21] followed this criterion for sus-
ceptibility testing and found that most of their nocardia strains
appeared susceptible to sulphonamides. In a recent publication,
Biehle et al. [22] compared E-test, microbroth dilution and the
disk-diffusion method for susceptibility testing of 52 clinical
isolates of Nocardia using 80% inhibition criterion for the
interpretation of TMP-SMX results. Eight per cent of the
isolates were found resistant to this drug. Concerning other
antimicrobials, amikacin, imipenem and cephalosporins have
been found to have maximum activity against N. asteroides with
resistant percentages not exceeding 15, 25 and 35, respectively.
Consistent with these observations, none of our soil isolates
were resistant to amikacin, imipenem, tobramycin, and resist-
ance to cephalosporins was less than 10%. More recently,
Ambaye et al. [23] compared five in vitro susceptibility methods
which included agar dilution, broth microdilution, disk
diffusion, E-test and the BACTEC Radiometric method.
When the results were combined for all antimicrobial agents
tested against all nocardia isolates by all methods and a standard
result for each Nocardia isolate was established by a consensus,
the BACTEC radiometric method produced the highest level
of agreement (97.9%). For TMP-SMX, the agar dilution
method showed 8% resistance, whereas all the other four
methods showed all the 26 isolates of Nocardia as susceptible.
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Demonstration of high resistance to b-lactam antibiotics in
nocardia species has been attributed to the presence of b-lac-
tamases [6] which were detectable in all the soil isolates by
Intralactam strips. Extrinsic or acquired resistance to b-lactam
antibiotics has been shown in 90% of the clinical isolates of
N. asteroides [6,24] and the isolate that showed lowest resistance
had no detectable b-lactamase activity [24]. Activity for b-
lactamases has been reported in several Nocardia species includ-
ing N. asteroides [24,25], N. brasiliensis [26,27] and N. farcinica
[28]. b-Lactamases of Nocardia species have been reported to be
either inducible [24] or noninducible [28] enzymes which may
be released into culture filtrate during growth or may be
obtained after cell disruption. Recently, Scopetti et al. [29]
reported a noninducible, mainly cell-associated b-lactamase in
a soil isolate of N. asteroides which was particularly abundant in
the stationary phase of the growth, and produced evidence of
its involvement in resistance to b-lactam antibiotics. It is appar-
ent that within Nocardia species/strains, there are differences in
the spectrum and kinetics of b-lactamases produced. Further
studies are needed to clarify whether differences in b-lactamases
could be correlated with variations in resistance to b-lactams
[30,31].
It may be emphasized here that in vitro antimicrobial sus-
ceptibility testing for nocardia species needs standardization,
both in terms of methodology and correlation with in vivo
therapeutic response [3,32,33]. The NCCLS is currently pur-
suing antimicrobial susceptibility testing methods for aerobic
actinomycetes which include modified disk diffusion, agar
dilution, broth microdilution, and radiometric growth index
[4,32]. It has been observed that media composition and inocu-
lum size considerably influence the in vitro results. Each test
technique requires a uniform homogeneous suspension but this
may not be achievable with all strains, since nocardiae grow as
long branching filaments that fragment and clump. Moreover,
some nocardia isolates do not show good growth on MHA [4].
Considering the inherent problems associated with anti-
microbial susceptibility testing of Nocardia and the wide vari-
ations which individual isolates exhibit, it is suggested that
susceptibility testing should be carried out by reference lab-
oratories. Moreover, there is need to develop a more reliable
methodology and interpretive criteria for susceptibility testing
of Nocardia species to minimize interlaboratory discrepancies.
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